Another SPRM, mifepristone, which has been proven to be effective and safe in the treatment of adenomyosis, has been shown in studies to affect the expression of caspase 3 in adenomyosis tissues and induce cell apoptosis through the mitochondria-dependent signaling pathway (Che et al., 2020). Here, CASP3 is linked to adenomyosis.